Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Al-Azhar University
Kern Medical Center
On Target Laboratories, LLC
On Target Laboratories, LLC
Masonic Cancer Center, University of Minnesota
Centre Francois Baclesse
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)